Optimizing the Resources of Psychotherapy as a Tool for Implementing the Mental Health Reform

NCT04017676 | Unknown

• 1 other identifier: Sha0006-19
• Study Type: interventional
• Target: 80
• Locations: 0 countries
• Sites: N/A

Brief Summary

Psychotherapy is one of the cornerstones in public and private mental health services. Despite the tremendous investment in psychotherapy, its efficiency ranges from 40% to 60%. Given the Mental health Reform (2015), aimed at increasing the quality, availability, and accessibility of mental health services, there is an urgent need to manage and maximize psychotherapy services in Israel.

Conditions

Psychotherapy Research and Outcome Measures

Outcome Measures

Primary Outcomes (1)

• Change in OQ45

  The primary outcome measure of the study is the OQ-45 (Lambert, M. J., Gregersen, A.T., Burlingame, G.M. (2004). The Outcome Questionnaire-45 The use of psychological testing for treatment planning and outcomes assessment: Volume 3: Instruments for adults (3rd ed) (pp. 191-234). Mahwah, NJ, US: Lawrence Erlbaum Associates Publishers).

  Initiation, Week 4, Week 7, Week 20

Study Arms (2)

Control group

NO INTERVENTION

The first group will be under the usual treatment conditions (TAU)

Experimental group

EXPERIMENTAL

The second group will be exposed to a multidisciplinary therapeutic program that has a monitoring component and after two months an intervening component will be.

Other: Supervision assissted by measures

Interventions

Supervision assissted by measures OTHER

In the weeks 10 and 13, about 72 hours after the meeting scheduled for that week, and before the next therapeutic session, there will be a structured training session (based on the recommendations of Krägeloh et al., 2015), based on information in the literature about the various questionnaires

Experimental group

Eligibility Criteria

• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• Included are patients over the age of 18 years who have agreed to participate in the study, were found suitable for psychotherapeutic treatment and are treated with the attending clinician for at least two months.

You may not qualify if:

• Patients who (due to cognitive impairment, language gaps, etc.) are not able to complete questionnaires with little help will not be included in the study. In order to minimize the effect of external variables, patients who, in the opinion of the clinician, are expected to undergo significant pharmacological changes (change in non-sleeping drugs or occasional sedatives) will not be included

Sponsors & Collaborators

• Shalvata Mental Health Center: lead
• Geha Mental Health Center: collaborator

Central Study Contacts

Shlomo Mendlovic, MD

CONTACT

972-50-6770178; mendlovic@clalit.org.il

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Model Details: A multicenter, randomized, controlled study with a group comparison and a program trial, in which the subjects are recruited according to a systematic allocation by order.

Study Record Dates

• First Submitted: July 9, 2019
• First Posted: July 12, 2019
• Study Start: October 1, 2020
• Primary Completion: January 1, 2021
• Study Completion: April 1, 2021
• Last Updated: July 12, 2019

Record last verified: 2019-07

Data Sharing

• IPD Sharing: Will not share